Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects

RW Foltin and MW Fischman

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Ten healthy adult male research volunteers with histories of smoked and i.v. cocaine use participated in four daily sessions. After resting base line, subjects received the same cocaine dose twice with a 14-min interval between doses. Cocaine hydrochloride (16 and 32 mg) was injected or cocaine base (25 and 50 mg) was smoked. Heart rate, blood pressure, subjective effects and venous blood were sampled repeatedly. The potency of smoked cocaine was about 60% of that of i.v. cocaine, i.e., a 50-mg dose of smoked cocaine had effects similar to a 32-mg dose of i.v. cocaine. Cocaine plasma level increased after each dose up to 425 ng/ml with peaks observed 4 min after the second dose. Plasma levels 44 min after the first dose were similar to plasma levels seen 4 min after the first dose. Smoked and i.v. cocaine produced similar increases in heart rate, blood pressure and rate pressure product at similar cocaine venous plasma levels. VAS ratings of "stimulated" and "high" were greater at similar plasma levels after smoked cocaine compared to i.v. cocaine. In addition VAS ratings of cocaine "liking" were also greater for smoked than i.v. cocaine. Otherwise the subjective effects of smoked and i.v. cocaine were similar. The effects of specific cocaine plasma levels on cardiovascular activity and some subjective reports were diminished across the session, demonstrating the development of acute tolerance to cocaine.

Volume 257, Issue 1, pp. 247-261, 04/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				D. A. Parasrampuria, K. A. Schoedel, R. Schuller, J. Gu, P. Ciccone, S. A. Silber, and E. M. Sellers Assessment of Pharmacokinetics and Pharmacodynamic Effects Related to Abuse Potential of a Unique Oral Osmotic-Controlled Extended-Release Methylphenidate Formulation in Humans J. Clin. Pharmacol., December 1, 2007; 47(12): 1476 - 1488. [Abstract] [Full Text] [PDF]

				References PsychiatryOnline CME, May 1, 2007; 2007(1): 2 - 2. [Full Text]

				P. Parikh, L. A. Nikolaidis, C. Stolarski, Y.-T. Shen, and R. P. Shannon Chronic Exposure to Cocaine Binging Predisposes to an Accelerated Course of Dilated Cardiomyopathy in Conscious Dogs following Rapid Ventricular Pacing J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1013 - 1019. [Abstract] [Full Text] [PDF]

				N. D. Volkow and J. M. Swanson Variables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD Am J Psychiatry, November 1, 2003; 160(11): 1909 - 1918. [Abstract] [Full Text] [PDF]

				K. Y. Little, L. W. Elmer, H. Zhong, J. O. Scheys, and L. Zhang Cocaine Induction of Dopamine Transporter Trafficking to the Plasma Membrane Mol. Pharmacol., February 1, 2002; 61(2): 436 - 445. [Abstract] [Full Text] [PDF]

				C. W. Bradberry Acute and Chronic Dopamine Dynamics in a Nonhuman Primate Model of Recreational Cocaine Use J. Neurosci., September 15, 2000; 20(18): 7109 - 7115. [Abstract] [Full Text] [PDF]

				C. W. Bradberry, R. L. Barrett-Larimore, P. Jatlow, and S. R. Rubino Impact of Self-Administered Cocaine and Cocaine Cues on Extracellular Dopamine in Mesolimbic and Sensorimotor Striatum in Rhesus Monkeys J. Neurosci., May 15, 2000; 20(10): 3874 - 3883. [Abstract] [Full Text] [PDF]

				H. E. Jones, B. E. Garrett, and R. R. Griffiths Subjective and Physiological Effects of Intravenous Nicotine and Cocaine in Cigarette Smoking Cocaine Abusers J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 188 - 197. [Abstract] [Full Text]

				M. J. Kaufman, J. M. Levin, M. H. Ross, N. Lange, S. L. Rose, T. J. Kukes, J. H. Mendelson, S. E. Lukas, B. M. Cohen, and P. F. Renshaw Cocaine-Induced Cerebral Vasoconstriction Detected in Humans With Magnetic Resonance Angiography JAMA, February 4, 1998; 279(5): 376 - 380. [Abstract] [Full Text] [PDF]

				M. Farré, R. De La Torre, M. L. González, M. T. Terán, P. N. Roset, E. Menoyo, and J. Camí Cocaine and Alcohol Interactions in Humans: Neuroendocrine Effects and Cocaethylene Metabolism J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 164 - 176. [Abstract] [Full Text]

				R. P. Shannon, P. Lozano, Q. Cai, W. T. Manders, and Y.-t. Shen Mechanism of the Systemic, Left Ventricular, and Coronary Vascular Tolerance to a Binge of Cocaine in Conscious Dogs Circulation, August 1, 1996; 94(3): 534 - 541. [Abstract] [Full Text]

				J. H. Mendelson and N. K. Mello Management of Cocaine Abuse and Dependence N. Engl. J. Med., April 11, 1996; 334(15): 965 - 972. [Full Text] [PDF]